Skip to main content
. Author manuscript; available in PMC: 2010 Nov 30.
Published in final edited form as: Nephron. 1987;46(Suppl 1):19–33. doi: 10.1159/000184431

Fig. 11.

Fig. 11

Events in patient OT 469, whose biopsy-proved rejection was reversed with OKT3 therapy. Treatment was started on the 6th postoperative day. Note the persistence of T3-positive lymphocytes in the circulation and T3 modulation during OKT3 therapy as well as the lymphocyte rebound after discontinuance of therapy. CyA = Ciclosporin. GOT = glutamic oxaloacetic transaminase; GPT = glutamic pyruvate transaminase.